Mark Mossler

CCCC

Mark Mossler serves as Chief Accounting Officer at C4 Therapeutics, Inc. (CCCC). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$11.2K

Net Position

Net Seller

$11.2K

Companies Traded

CCCC

Active Period

Feb 2025 – Feb 2026

2 total trades

Most Recent

Sell CCCC

Feb 13, 2026 · $6.2K

Mark Mossler's Insider Trading at C4 Therapeutics, Inc. (CCCC)

Buys

0 · $0.00

Sells

2 · $11.2K

Total Shares Bought

Total Shares Sold

4,854

CCCC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 13, 2026	Sell	3,268	$1.89	$6.2K	0
Feb 14, 2025	Sell	1,586	$3.18	$5.0K	0

Related Insiders

Andrew Hirsch

President & CEO

CCCCSell · Feb 18, 2026

Kendra Adams

Chief Financial Officer

CCCCSell · Feb 13, 2026

Scott N Boyle

Chief Business Officer

CCCCSell · Feb 13, 2026

Paige Mahaney

Chief Scientific Officer

CCCCSell · Feb 13, 2026

REYNO LEONARD

Chief Medical Officer

CCCCSell · Feb 13, 2026

Explore More Insider Trading Data

CCCC Insider Trading Activity

View all insider trades at C4 Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity